PRMT5 inhibitors on the (myeloma) road

Oncotarget. 2018 Nov 30;9(94):36646-36647. doi: 10.18632/oncotarget.26392.

Authors

Annamaria Gulla¹, Teru Hideshima¹, Kenneth C Anderson¹

Affiliation

¹ Jerome Lipper Multiple Myeloma Center, Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA.

No abstract available

Keywords: PRMT5; PTM; epigenetics; methylation; myeloma.

Publication types

Editorial